Teriflunomide Tablet, Film Coated
Product Images NDC 70377-017

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 70377-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel- 7 mg Tablet Sleeve (7mg Sleeve)

Principal Display Panel- 7 mg Tablet Sleeve (7mg Sleeve)
This text provides the National Drug Code (NDC) and drug name Teriflunomide for tablets.*
FDA Label Image

Principal Display Panel- 7 mg Tablet Bottle (Bottle7s)

Principal Display Panel- 7 mg Tablet Bottle (Bottle7s)
This is a medication guide for Teriflunomide Tablets containing 7mg of Teriflunomide in each tablet. The recommended dosage is one tablet orally once daily with or without food. The medication is to be kept out of reach of children and stored in a child-resistant package at a temperature range of 68°F to 77°F (20°C to 25°C), with permitted excursions between 59°F and 86°F (15°C and 30°C). It is manufactured by Biocon Pharma Limited, India, and distributed by Biocon Pharma Inc, in Iselin, NJ, USA. The package includes 30 tablets, and each tablet comes with the enclosed Medication Guide.*
FDA Label Image

Chemical Structure (Teriflunomide 01)

FDA Label Image

Figure 1 (Teriflunomide 02)

FDA Label Image

Figure 2 (Teriflunomide 03)

Figure 2 (Teriflunomide 03)
This is a table showing the percentage of sustained progression over a period of 12 weeks, with two specified time points. However, the table is not readable as the result appears to be unclear or corrupted.*
FDA Label Image

Principal Display Panel (7 mg Tablet Carton)

Principal Display Panel (7 mg Tablet Carton)
Teriflunomide is a medication administered to adults via a tablet taken once per day with or without food. Each tablet includes 7mg of Teriflunomide with a typical prescription requiring a 28 tablet supply. Patients should be provided with the enclosed medication guide, and children should be advised against accessing the pills. The recommended storage temperature and handling instructions are included along with a child-resistant package design. The manufacturer is Biocon Pharma with the manufacturing locations being Iselin, NJ, and Bengaluru, India. Instructions on opening the blister card and extracting the tablets are also provided.*
FDA Label Image

Principal Display Panel- 7 mg Tablet Blister (Teriflunomide 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.